Skip to content
Preclinical Data Forum

Global Preclinical Data Forum and European College of Neuropsychopharmacology
Announce the Winner of the 2020 Best Negative Data Prize

Learn More

Who We Are

The Global Preclinical Data Forum is a jointly sponsored U.S. and European initiative that encourages global collaboration to address the challenge of ensuring that preclinical research is reproducible, robust and translatable to support disease research utility for clinical research & development (R&D).
United States Sponsor:
European Sponsor:

News & Events

Global Preclinical Data Forum and European College of Neuropsychopharmacology Announce the Winner of the 2020 Best Negative Data Prize
The Global Preclinical Data Forum (GPDF), a jointly sponsored U.S. and European initiative, funded by Cohen Veterans Bioscience (CVB) and the European College of Neuropsychopharmacology (ECNP), announced today the winner of the 2020 "Best Negative Data Prize." The prize is awarded to the researcher or research group whose neuroscience study best exemplifies data where the outcomes do not confirm the expected results or working hypothesis. The goal of the unusual award is to incentivize researchers to publish negative findings to demonstrate that all data holds value for the scientific process.
Global Preclinical Data Forum Announces 2020 Negative Data Prize Award
The Global Preclinical Data Forum (GPDF), a partnership of Cohen Veterans Bioscience (CVB), a non-profit research biotech, and the European College of Neuropsychopharmacology (ECNP), is pleased to announce the opening of submissions for the 2020 Best Negative Data Prize competition.